1
|
Singer M, Deutschman CS, Seymour CW,
Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche
JD, Coopersmith CM, et al: The third international consensus
definitions for sepsis and septic shock (Sepsis-3). JAMA.
315:801–810. 2016. View Article : Google Scholar : PubMed/NCBI
|
2
|
Cecconi M, Evans L, Levy M and Rhodes A:
Sepsis and septic shock. Lancet. 392:75–87. 2018. View Article : Google Scholar : PubMed/NCBI
|
3
|
Gobatto AL, Besen BA and Azevedo LC: How
can we estimate sepsis incidence and mortality? Shock 47 (1S Suppl
1). S6–S11. 2017.
|
4
|
Martin GS: Sepsis, severe sepsis and
septic shock: Changes in incidence, pathogens and outcomes. Expert
Rev Anti Infect Ther. 10:701–706. 2012. View Article : Google Scholar : PubMed/NCBI
|
5
|
Mayr FB, Yende S and Angus DC:
Epidemiology of severe sepsis. Virulence. 5:4–11. 2014. View Article : Google Scholar : PubMed/NCBI
|
6
|
Vincent JL: Individual gene expression and
personalised medicine in sepsis. Lancet Respir Med. 4:242–243.
2016. View Article : Google Scholar : PubMed/NCBI
|
7
|
Maslove DM and Wong HR: Gene expression
profiling in sepsis: Timing, tissue, and translational
considerations. Trends Mol Med. 20:204–213. 2014. View Article : Google Scholar : PubMed/NCBI
|
8
|
Ullah S, John P and Bhatti A: MicroRNAs
with a role in gene regulation and in human diseases. Mol Biol Rep.
41:225–232. 2014. View Article : Google Scholar : PubMed/NCBI
|
9
|
Eledge MR and Yeruva L: Host and pathogen
interface: MicroRNAs are modulators of disease outcome. Microbes
Infect. 20:410–415. 2018. View Article : Google Scholar : PubMed/NCBI
|
10
|
Chen J, Jiang S, Cao Y and Yang Y: Altered
miRNAs expression profiles and modulation of immune response genes
and proteins during neonatal sepsis. J Clin Immunol. 34:340–348.
2014. View Article : Google Scholar : PubMed/NCBI
|
11
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-update. Nucleic Acids Res. 41:D991–D995. 2013.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Rittirsch D, Huber-Lang MS, Flierl MA and
Ward PA: Immunodesign of experimental sepsis by cecal ligation and
puncture. Nat Protoc. 4:31–36. 2009. View Article : Google Scholar : PubMed/NCBI
|
13
|
Kanehisa M, Sato Y, Furumichi M, Morishima
K and Tanabe M: New approach for understanding genome variations in
KEGG. Nucleic Acids Res. 47:D590–D595. 2019. View Article : Google Scholar : PubMed/NCBI
|
14
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
15
|
Borken F, Markwart R, Requardt RP,
Schubert K, Spacek M, Verner M, Rückriem S, Scherag A, Oehmichen F,
Brunkhorst FM and Rubio I: Chronic critical illness from sepsis is
associated with an enhanced TCR response. J Immunol. 198:4781–4791.
2017. View Article : Google Scholar : PubMed/NCBI
|
16
|
Patil NK, Bohannon JK, Luan L, Guo Y,
Fensterheim B, Hernandez A, Wang J and Sherwood ER: Flt3 ligand
treatment attenuates T cell dysfunction and improves survival in a
murine model of burn wound sepsis. Shock. 47:40–51. 2017.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Ramonell KM, Zhang W, Hadley A, Chen CW,
Fay KT, Lyons JD, Klingensmith NJ, McConnell KW, Coopersmith CM and
Ford M: CXCR4 blockade decreases CD4+ T cell exhaustion and
improves survival in a murine model of polymicrobial sepsis. PLoS
One. 12:e01888822017. View Article : Google Scholar : PubMed/NCBI
|
18
|
Oami T, Watanabe E, Hatano M, Sunahara S,
Fujimura L, Sakamoto A, Ito C, Toshimori K and Oda S: Suppression
of T cell autophagy results in decreased viability and function of
T cells through accelerated apoptosis in a murine sepsis model.
Crit Care Med. 45:e77–e85. 2017. View Article : Google Scholar : PubMed/NCBI
|
19
|
Cao C, Chai Y, Shou S, Wang J, Huang Y and
Ma T: Toll-like receptor 4 deficiency increases resistance in
sepsis-induced immune dysfunction. Int Immunopharmacol. 54:169–176.
2018. View Article : Google Scholar : PubMed/NCBI
|
20
|
Condotta SA, Khan SH, Rai D, Griffith TS
and Badovinac VP: Polymicrobial sepsis increases susceptibility to
chronic viral infection and exacerbates CD8+ T cell
exhaustion. J Immunol. 195:116–125. 2015. View Article : Google Scholar : PubMed/NCBI
|
21
|
Hotchkiss RS, Tinsley KW, Swanson PE,
Schmieg RE Jr, Hui JJ, Chang KC, Osborne DF, Freeman BD, Cobb JP,
Buchman TG and Karl IE: Sepsis-induced apoptosis causes progressive
profound depletion of B and CD4+ T lymphocytes in humans. J
Immunol. 166:6952–6963. 2001. View Article : Google Scholar : PubMed/NCBI
|
22
|
van der Poll T, van de Veerdonk FL,
Scicluna BP and Netea MG: The immunopathology of sepsis and
potential therapeutic targets. Nat Rev Immunol. 17:407–420. 2017.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Boomer JS, To K, Chang KC, Takasu O,
Osborne DF, Walton AH, Bricker TL, Jarman SD II, Kreisel D,
Krupnick AS, et al: Immunosuppression in patients who die of sepsis
and multiple organ failure. JAMA. 306:2594–2605. 2011. View Article : Google Scholar : PubMed/NCBI
|
24
|
Inoue S, Suzuki K, Komori Y, Morishita Y,
Suzuki-Utsunomiya K, Hozumi K, Inokuchi S and Sato T: Persistent
inflammation and T cell exhaustion in severe sepsis in the elderly.
Crit Care. 18:R1302014. View
Article : Google Scholar : PubMed/NCBI
|
25
|
Gil D, Schrum AG, Daniels MA and Palmer E:
A role for CD8 in the developmental tuning of antigen recognition
and CD3 conformational change. J Immunol. 180:3900–3909. 2008.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Harty JT, Tvinnereim AR and White DW: CD8+
T cell effector mechanisms in resistance to infection. Annu Rev
Immunol. 18:275–308. 2000. View Article : Google Scholar : PubMed/NCBI
|
27
|
Dumontet E, Osman J, Guillemont-Lambert N,
Cros G, Moshous D and Picard C: Recurrent respiratory infections
revealing CD8α Deficiency. J Clin Immunol. 35:692–695. 2015.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Harland KL, Day EB, Apte SH, Russ BE,
Doherty PC, Turner SJ and Kelso A: Epigenetic plasticity of Cd8a
locus during CD8(+) T-cell development and effector differentiation
and reprogramming. Nat Commun. 5:35472014. View Article : Google Scholar : PubMed/NCBI
|
29
|
Irving BA and Weiss A: The cytoplasmic
domain of the T cell receptor zeta chain is sufficient to couple to
receptor-associated signal transduction pathways. Cell. 64:891–901.
1991. View Article : Google Scholar : PubMed/NCBI
|
30
|
D'Oro U, Munitic I, Chacko G, Karpova T,
McNally J and Ashwell JD: Regulation of constitutive TCR
internalization by the zeta-chain. J Immunol. 169:6269–6278. 2002.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Eldor R, Klieger Y, Sade-Feldman M, Vaknin
I, Varfolomeev I, Fuchs C and Baniyash M: CD247, a novel T
cell-derived diagnostic and prognostic biomarker for detecting
disease progression and severity in patients with type 2 diabetes.
Diabetes Care. 38:113–118. 2015. View Article : Google Scholar : PubMed/NCBI
|
32
|
Picard C, Dogniaux S, Chemin K,
Maciorowski Z, Lim A, Mazerolles F, Rieux-Laucat F, Stolzenberg MC,
Debre M, Magny JP, et al: Hypomorphic mutation of ZAP70 in human
results in a late onset immunodeficiency and no autoimmunity. Eur J
Immunol. 39:1966–1976. 2009. View Article : Google Scholar : PubMed/NCBI
|
33
|
Roifman CM, Dadi H, Somech R, Nahum A and
Sharfe N: Characterization of ζ-associated protein, 70 kd
(ZAP70)-deficient human lymphocytes. J Allergy Clin Immunol.
126:1226–1233.e1. 2010. View Article : Google Scholar : PubMed/NCBI
|
34
|
Huang L, Qiao L, Zhu H, Jiang L and Yin L:
Genomics of neonatal sepsis: Has-miR-150 targeting BCL11B functions
in disease progression. Ital J Pediatr. 44:1452018. View Article : Google Scholar : PubMed/NCBI
|
35
|
Hayden MS and Ghosh S: Shared principles
in NF-kappaB signaling. Cell. 132:344–362. 2008. View Article : Google Scholar : PubMed/NCBI
|
36
|
Perkins ND: Integrating cell-signalling
pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol.
8:49–62. 2007. View Article : Google Scholar : PubMed/NCBI
|
37
|
Pannicke U, Baumann B, Fuchs S, Henneke P,
Rensing-Ehl A, Rizzi M, Janda A, Hese K, Schlesier M, Holzmann K,
et al: Deficiency of innate and acquired immunity caused by an
IKBKB mutation. N Engl J Med. 369:2504–2514. 2013. View Article : Google Scholar : PubMed/NCBI
|
38
|
Mousallem T, Yang J, Urban TJ, Wang H,
Adeli M, Parrott RE, Roberts JL, Goldstein DB, Buckley RH and Zhong
XP: A nonsense mutation in IKBKB causes combined immunodeficiency.
Blood. 124:2046–2050. 2014. View Article : Google Scholar : PubMed/NCBI
|